Eterna Therapeutics
NASDAQ: ERNA
$2.02
+0.07
(+3.59%)
as on
Eterna Therapeutics Stock Performance
as on November 4, 2026 at 7:59 am IST
Day's Low
Day's High
$1.99$2.12
1.49%
Downside
4.95%
Upside
52 Week's Low
52 Week's High
$1.84$47.258.98%
Downside
2239.11%
Upside
Eterna Therapeutics share price movements today
- Previous Close
- $1.95
- Open
- $2.08
- Volume
- 530.3K
- Market Cap
- $3.2M
- Day's Low - High
- $1.99 - $2.12
- 52 Week Low - High
- $1.84 - $47.25
Eterna Therapeutics Historical Returns
- 1 Month Return
- -34.12 %
- 3 Month Return
- -43.48 %
- 1 Year Return
- -95.33 %
- 3 Year Return
- -99.6 %
- 5 Year Return
- 0 %
Eterna Therapeutics Stock Fundamentals & Key Indicators
Check Eterna Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.2M
EPS (TTM)
-18.85
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.1
Industry PE ratio
-3.13
PEG Ratio
-0.00
EBITDA
-17.4M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-305.85%
Eterna Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Eterna Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Hold | $3.2M | NA | -0.10 | 0.00% | 0.00% | |
| Neutral | $88.5B | -36.16% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 192.56% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 47.41% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for Eterna Therapeutics Stock including INR - Dollar returns
The Eterna Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Eterna Therapeutics investment value today
Current value as on today
₹5,166
Returns
Returns from Eterna Therapeutics Stock
Dollar Impact
₹328 (+0.33%)
Analyst Recommendation on Eterna Therapeutics Stock
Based on 6 analysts
0.00%
Buy
50.00%
Hold
50.00%
Sell
Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for Eterna Therapeutics. Average target price of $30
Eterna Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Eterna Therapeutics.
What analysts predicted
93.27%UPSIDE
Target Price
$30
Current Price
$2.02
Analyzed by
6 Analysts
Target
$30.00
Eterna Therapeutics target price $30, a slight upside of 93.27% compared to current price of $2.02. According to 6 analysts rating.
Indian Investors' Interest in Eterna Therapeutics Stock
Search interest for Eterna Therapeutics Stock has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Eterna Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Eterna Therapeutics Annual Profit & Loss
All numbers in Millions USD
Eterna Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Eterna Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Eterna Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 881.8%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 184.8% return, outperforming this stock by 284.4%
NEGATIVE IMPACTPrice Dip
In the last 1 month, ERNA stock has moved down by -34.1%
About Eterna Therapeutics
| Organisation | Eterna Therapeutics |
| Headquarters | 10355 Science Center Drive, Cambridge, MA, 02141, US |
| Industry | Biotechnology |
| CEO | Sanjeev Luther |
Key Management of Eterna Therapeutics
Name | Title |
|---|---|
Mr. Sanjeev Luther | CEO, President & Director |
Mr. Mark J. Keeley CPA, CITP, M.B.A. | Chief Financial Officer |
Ms. Deborah Vee Wild | Head of CMC & Operations |
Dr. Robert Hamilton Pierce M.D. | Chief Scientific Officer |
Ms. Dorothy J. Clarke | General Counsel |
FAQs
What is Eterna Therapeutics share price today?
Eterna Therapeutics share price today is $2.02 as on at the close of the market. Eterna Therapeutics share today touched a day high of $2.12 and a low of $1.99.
What is the 52 week high and 52 week low for Eterna Therapeutics share?
Eterna Therapeutics share touched a 52 week high of $47.25 on and a 52 week low of $1.84 on . Eterna Therapeutics stock price today i.e. is closed at $2.02,which is 95.72% down from its 52 week high and 9.86% up from its 52 week low.
What is Eterna Therapeutics's market capitalisation today?
Eterna Therapeutics market capitalisation is $0.00T as on .
How to invest in Eterna Therapeutics Stock (ERNA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Eterna Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Eterna Therapeutics Stock (ERNA) from India?
Indian investors can start investing in Eterna Therapeutics (ERNA) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Eterna Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Eterna Therapeutics share’s latest price of $2.02 as on November 4, 2026 at 2:29 am IST, you will get 4.9505 shares of Eterna Therapeutics. Learn more about
fractional shares .